A+ | A | A- | Skip to main content |

800 years stamp

Sensex

Nifty

USDINR

GBPINR

EURINR

BSE
NSE

Thursday, 18 June 2026 12:00 AM EOD	Asian-Paints2755.05	Hind-Unilever2218.50	ITC291.10	Trent3179.70	Larsen-and-Toubro4189.60	M-and-M3140.95	Reliance-Industries1327.75	Tata-Steel200.55	Titan-Company4386.35	SBI1042.85	Bharat-Electron428.55	Kotak-Mah-Bank402.95	Infosys1127.25	Bajaj-Finance959.10	Sun-PharmaInds1824.00	HDFC-Bank798.55	TCS2204.30	ICICI-Bank1342.55	Power-Grid-Corpn288.60	Maruti-Suzuki13481.20	Axis-Bank1360.55	HCL-Technologies1161.65	NTPC362.00	Bharti-Airtel1874.80	Tech-Mahindra1446.60	Adani-Ports1842.80	UltraTech-Cem11434.05	Bajaj-Finserv1771.30	Interglobe-Aviat5011.70	Eternal258.50
15 mins delay SENSEX 77,409.98 [254.36]	18.05 0.66%	20.55 0.93%	0.35 0.12%	78.05 2.52%	-17.35 -0.41%	7.80 0.25%	-4.80 -0.36%	1.55 0.78%	4.70 0.11%	16.85 1.64%	8.75 2.08%	-1.55 -0.38%	-30.85 -2.66%	1.00 0.10%	4.05 0.22%	11.75 1.49%	-18.30 -0.82%	5.80 0.43%	2.25 0.79%	-150.30 -1.10%	9.60 0.71%	-4.80 -0.41%	6.60 1.86%	-0.70 -0.04%	-15.40 -1.05%	14.70 0.80%	64.70 0.57%	6.55 0.37%	133.40 2.73%	0.00 0.00%

Hot Pursuit

Scrips, which has significant changes during the market hours.

Cohance Lifesciences CFO Himanshu Agarwal resigns to pursue opportunity outside company

18-Jun-26 16:11Hrs IST

According to the company's regulatory filing, Agarwal will be relieved from his duties with effect from the close of business hours on September 13, 2026.

Agarwal served as a whole-time director and key managerial personnel (KMP) of the company. The resignation is not linked to any material concerns and has been submitted to enable him to pursue opportunities outside the organisation.

The company has not yet announced a successor for the CFO role.

Cohance Lifesciences, formerly Suven Pharmaceuticals, is an innovator-focused global CRDMO formed through the merger of Cohance Life Sciences into Suven Pharmaceuticals. It is a technology-driven, integrated CDMO platform offering development and manufacturing solutions across complex APIs, performance materials, agrochemicals, ADCs, oligonucleotides and advanced chemistries for global pharmaceutical and life sciences customers.

The company's consolidated net profit tanked 66.8% to Rs 44.67 crore on 26.2% decline in revenue from operations to Rs 567.55 crore in Q4 FY26 over Q4 FY25.

The scrip declined 2.42% to end at Rs 415.55 on the BSE.

Powered by Capital Market - Live News

Attention Investor :

"Prevent unauthorised transactions in your account ; Update your mobile numbers/email IDs with Us. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day” - Issued in the interest of Investors"

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

"No need to issue cheques by investors while subscribing to Equity IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

"Contents which are exclusively for Non-Broking Products/Services, "Mutual Fund, Mutual Fund-SIP, Research reports, Insurance, etc. where the Member is just a distributor. These are not Exchange traded product and the Member is just acting as distributor. It should also state that all disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism."

A Muthoot M George Enterprise